Mereo Biopharma Group Plc ADR (MREO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,802 | 57,421 | 68,182 | N/A | 30,134 |
| Marketable Securities | N/A | N/A | N/A | 129,666 | N/A |
| Receivables | N/A | N/A | N/A | 3,064 | 2,337 |
| Other current assets | 2,786 | 1,183 | 1,569 | 0 | 3,618 |
| TOTAL | $74,763 | $63,760 | $75,197 | $136,579 | $38,168 |
| Non-Current Assets | |||||
| PPE Net | 257 | 405 | 551 | 3,479 | 2,020 |
| Intangibles | 643 | 1,089 | 0 | 33,778 | 40,636 |
| Other Non-Current Assets | 727 | 1,245 | 1,665 | 0 | 0 |
| TOTAL | $1,627 | $2,739 | $2,216 | $37,257 | $42,656 |
| Total Assets | $76,390 | $66,499 | $77,413 | $173,836 | $80,824 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,440 | 2,346 | 3,492 | 3,436 | 4,280 |
| Accrued Expenses | 4,071 | 5,467 | 5,436 | 5,261 | 5,365 |
| Other current liabilities | 1,095 | 1,021 | 1,557 | 5,599 | 537 |
| TOTAL | $13,848 | $9,486 | $24,375 | $17,245 | $10,998 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 19,779 | 20,726 |
| Other Non-Current Liabilities | 1,573 | 6,476 | 1,636 | 15,800 | 68,323 |
| TOTAL | $1,573 | $6,476 | $1,636 | $35,579 | $89,049 |
| Total Liabilities | $15,421 | $15,962 | $26,011 | $52,825 | $100,047 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 159,000 | N/A | N/A | N/A | N/A |
| Common Shares | 3,059 | 2,775 | 2,478 | 2,413 | 1,306 |
| Retained earnings | -462,883 | -419,630 | -404,575 | -408,361 | -397,646 |
| Other shareholders' equity | -18,849 | -17,715 | -22,022 | 8,141 | 4,553 |
| TOTAL | $60,969 | $50,537 | $51,402 | $121,012 | $-19,223 |
| Total Liabilities And Equity | $76,390 | $66,499 | $77,413 | $173,836 | $80,824 |